The Bacteriocin Sublancin Attenuates Intestinal Injury in Young Mice Infected With Staphylococcus aureus

Anatomical Record

Volumn 297, Issue 8, 2014, Pages 1454-1461

  Wang, Qingwei ^a   Zeng, Xiangfang ^a   Wang, Shuai ^a   Hou, Chengli ^a   Yang, Fengjuan ^a   Ma, Xi ^a   Thacker, Philip ^b   Qiao, Shiyan ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Bacteriocin; Intestine; Peptide; Staphylococcus aureus; Sublancin

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BACTERIOCIN; SODIUM CHLORIDE; SUBLANCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG MEGADOSE; DRUG POTENCY; EXPERIMENTAL DIGESTIVE SYSTEM DISEASE; EXPERIMENTAL INFECTION; FEMALE; INOCULATION; INTESTINE CELL; INTESTINE INJURY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; DRUG EFFECTS; ENZYME IMMUNOASSAY; INJURIES; INTESTINE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; STAPHYLOCOCCAL INFECTIONS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOCINS; BLOTTING, WESTERN; CELLS, CULTURED; FEMALE; IMMUNOENZYME TECHNIQUES; INTESTINES; MALE; MICE; MICROBIAL SENSITIVITY TESTS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84904060203     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.22941     Document Type: Article

References (35)

1. Aly S, Floury J, Piot M, Lortal S, Jeanson S. 2012. The efficacy of nisin can drastically vary when produced in situ in model cheeses. Food Microbiol 32:185-190.
2. Barie PS. 1998. Antibiotic-resistant gram-positive cocci: implications for surgical practice. World J Surg 22:118-126.
3. Blau H, Klein K, Shalit I, Halperin D, Fabian I. 2007. Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line. Am J Physiol Lung Cell Mol Physiol 292:L343-L352.
4. Cao LT, Wu JQ, Xie F, Hu SH, Mo Y. 2007. Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows. J Dairy Sci 90:3980-3985.
5. Chaturvedi LS, Basson MD. 2013. Glucagonlike Peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells. JAMA Surg 148:1037-1042.
6. Cruz-Chamorro L, Puertollano MA, Puertollano E, de Cienfuegos GA, de Pablo MA. 2006. In vitro biological activities of magainin alone or in combination with nisin. Peptides 27:1201-1209.
7. Finlay BB, McFadden G. 2006. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124:767-782.
8. Fischer CD, Beatty JK, Zvaigzne CG, Morck DW, Lucas MJ, Buret AG. 2011. Anti-Inflammatory benefits of antibiotic-induced neutrophil apoptosis: tulathromycin induces caspase-3-dependent neutrophil programmed cell death and inhibits NF-kappaB signaling and CXCL8 transcription. Antimicrob Agents Chemother 55:338-348.
9. Frimodt-Moller N. 1993. The mouse peritonitis model: present and future use. J Antimicrob Chemother 31:55-60.
10. Fu WJ, Stromberg AJ, Viele K, Carroll RJ, Wu G. 2010. Statistics and bioinformatics in nutritional sciences: analysis of complex data in the era of systems biology. J Nutr Biochem 21:561-572.
11. Haidet J, Cifarelli V, Trucco M, Luppi P. 2012. C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia. Inflamm Res 61:27-35.
12. Hayden MS, Ghosh S. 2008. Shared principles in NF-kappaB signaling. Cell 132:344-362.
13. Hsieh YS, Wilkinson BL, O'Connell MR, Mackay JP, Matthews JM, Payne RJ. 2012. Synthesis of the bacteriocin glycopeptide sublancin 168 and S-glycosylated variants. Org Lett 14:1910-1913.
14. Karin M. 1999. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem 274:27339-27342.
15. Knudsen JD, Fuursted K, Raber S, Espersen F, Frimodt-Moller N. 2000. Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection. Antimicrob Agents Chemother 44:1247-1254.
16. Kouwen TR, Trip EN, Denham EL, Sibbald MJ, Dubois JY, van Dijl JM. 2009. The large mechanosensitive channel MscL determines bacterial susceptibility to the bacteriocin sublancin 168. Antimicrob Agents Chemother 53:4702-4711.
17. Kwiatek M, Parasion S, Mizak L, Gryko R, Bartoszcze M, Kocik J. 2012. Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains. Arch Virol 157:225-234.
18. Lazarevic V, Dusterhoft A, Soldo B, Hilbert H, Mauel C, Karamata D. 1999. Nucleotide sequence of the Bacillus subtilis temperate bacteriophage SPbetac2. Microbiology 145:1055-1067.
19. Lowy FD. 1998. Staphylococcus aureus infections. N Engl J Med 339:520-532.
20. Lu Y, Hu YL, Kong XF, Wang DY. 2008. Selection of component drug in activating blood flow and removing blood stasis of Chinese herbal medicinal formula for dairy cow mastitis by hemorheological method. J Ethnopharmacol 116:313-317.
21. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C. 2001. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121:580-591.
22. McPherson S, Ellis R, Fawzi H, Panter SJ. 2005. Postoperative methicillin-resistant Staphylococcus aureus enteritis following hysterectomy: a case report and review of the literature. Eur J Gastroenterol Hepatol 17:1225-1227.
23. Nakamura Y, Aramaki Y, Kakiuchi T. 2001. A mouse model for postoperative fatal enteritis due to Staphylococcus infection. J Surg Res 96:35-43.
24. Nam C, Case AJ, Hostager BS, O'Dorisio MS. 2009. The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation. J Mol Neurosci 37:160-167.
25. Paik SH, Chakicherla A, Hansen JN. 1998. Identification and characterization of the structural and transporter genes for, and the chemical and biological properties of, sublancin 168, a novel lantibiotic produced by Bacillus subtilis 168. J Biol Chem 273:23134-23142.
26. Pieper L, Godkin A, Roesler U, Polleichtner A, Slavic D, Leslie KE, Kelton DF. 2012. Herd characteristics and cow-level factors associated with Prototheca mastitis on dairy farms in Ontario, Canada. J Dairy Sci 95:5635-5644.
27. Pilla R, Bonura C, Malvisi M, Snel GG, Piccinini R. 2013. Methicillin-resistant Staphylococcus pseudintermedius as causative agent of dairy cow mastitis. Vet Rec 173:19.
28. Prado Montes de Oca E. 2013. Antimicrobial peptide elicitors: new hope for the post-antibiotic era. Innate Immun 19:227-241.
29. Riboulet-Bisson E, Sturme MH, Jeffery IB, O'Donnell MM, Neville BA, Forde BM, Claesson MJ, Harris H, Gardiner GE, Casey PG, Lawlor PG, O'Toole PW, Ross RP. 2012. Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota. PLoS One 7:e31113.
30. Runciman DJ, Malmo J, Deighton M. 2010. The use of an internal teat sealant in combination with cloxacillin dry cow therapy for the prevention of clinical and subclinical mastitis in seasonal calving dairy cows. J Dairy Sci 93:4582-4591.
31. Sacre SM, Lundberg AM, Andreakos E, Taylor C, Feldmann M, Foxwell BM. 2007. Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-kappaB activation and cytokine production in primary human cells: TRAM is an adaptor for LPS and LTA signaling. J Immunol 178:2148-2154.
32. Stadnyk AW. 2002. Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. Can J Gastroenterol 16:241-246.
33. Waseem T, Frcs MD, Ashley SW, Robinson MK. 2013. Ghrelin promotes intestinal epithelial cell proliferation through PI3K/Akt pathway and EGFR trans-activation both converging to ERK 1/2 phosphorylation. Peptides 52:113-121.
34. Wraight MD. 2005. A comparative field trial of cephalonium and cloxacillin for dry cow therapy for mastitis in Australian dairy cows. Aust Vet J 83:103;author reply 103-104.
35. Wu S, Zhang F, Huang Z, Liu H, Xie C, Zhang J, Thacker PA, Qiao S. 2012. Effects of the antimicrobial peptide cecropin AD on performance and intestinal health in weaned piglets challenged with Escherichia coli. Peptides 35:225-230.